The ability of breast tumour cells to orchestrate angiogenesis is provided for by their ability to secrete NDPK, which can result in transactivation of the VEGF receptor-2 even in the absence of VEGF (Figure 2A). This evidence concerns the gene VEGFA and breast neoplasm.